• Biotin-16-UTP: Technical Guidance for RNA Labeling Workflows

  2026-06-02

  Biotin-16-UTP addresses the need for robust, specific RNA labeling in complex molecular biology workflows, such as RNA detection, purification, and interaction studies. Its use is recommended for in vitro transcription-based RNA labeling but not for diagnostic or clinical applications.

• Methotrexate as a Folate Antagonist: Advanced Research Workf

  2026-06-01

  Methotrexate’s dual action as a folate antagonist and immunosuppressive agent enables precise modeling of apoptotic and anti-inflammatory pathways. Leveraging innovations in assay design and permeability screening, researchers can achieve higher reproducibility and translational relevance across immunology, oncology, and pharmacokinetics studies.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-06-01

  This study delineates how ambroxol modulates human Nav1.8 sodium channels and the irritant receptors TRPV1 and TRPA1, key targets in the topical treatment of neuropathic pain. The findings clarify species-specificity, mechanisms of channel inhibition, and ambroxol’s interaction with capsaicin-induced TRPV1 activity, informing future research on targeted analgesic strategies.

• Indomethacin Sodium Trihydrate: COX Inhibitor for Inflammati

  2026-05-31

  Indomethacin Sodium Trihydrate is a non-selective COX inhibitor used in inflammation and pain signaling pathway research. Rigorous evidence supports its efficacy in prostaglandin synthesis inhibition and remyelination assays, with well-defined in vitro and in vivo protocols.

• GS-441524 Prodrug: Advanced Pharmacokinetics and Assay Impli

  2026-05-30

  Explore the multifaceted pharmacokinetics and analytical strategies for GS-441524, a leading nucleoside analog in antiviral research. This article uniquely deciphers conversion pathways and practical assay parameters, offering actionable insights for GS-441524 prodrug studies.

• Deferasirox Fe3+ Chelate: Mechanistic Precision for Iron Ove

  2026-05-29

  This thought-leadership article explores the mechanistic underpinnings, translational strategy, and practical laboratory integration of Deferasirox Fe3+ chelate (Exjade) for iron overload treatment research. Through a synthesis of peer-reviewed evidence and hands-on workflow guidance, it positions APExBIO's Deferasirox Fe3+ chelate as a pivotal tool for advancing beta-thalassemia iron chelation, chronic anemia iron management, and the next generation of iron metabolism studies.

• Remdesivir (GS-5734): Advancing Antiviral Translation

  2026-05-29

  Explore how Remdesivir (GS-5734) is redefining RNA virus research, offering mechanistic insight and translational strategy for researchers facing emerging threats like SARS-CoV, MERS-CoV, and Ebola. This article bridges experimental rigor with future-focused guidance, integrating the latest findings and competitive context.

• Nirmatrelvir (PF-07321332): Optimizing SARS-CoV-2 Replicatio

  2026-05-28

  Nirmatrelvir (PF-07321332) empowers antiviral researchers to dissect SARS-CoV-2 replication dynamics with precision. This guide details experimental workflows, advanced troubleshooting, and real-world enhancements for leveraging this 3CL protease inhibitor in COVID-19 research.

• GPNMB-Based Model Predicts Immunotherapy Response in ESCC

  2026-05-28

  This study establishes a clinically scalable, multimodal model integrating circulating GPNMB levels and CAF-Epi niche features to predict immunotherapy outcomes in esophageal squamous cell carcinoma (ESCC). The model elucidates tumor–immune crosstalk mechanisms underlying resistance to PD-1 blockade and provides robust, actionable biomarkers for patient stratification and precision oncology.

• GPNMB-Based Multimodal Model Predicts ESCC Immunotherapy Res

  2026-05-27

  This study introduces a clinically validated, multimodal model integrating circulating GPNMB and tumor microenvironment features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). By uncovering the mechanistic role of soluble GPNMB in CD8+ T cell exhaustion, the research advances patient stratification for precision immunotherapy.

• Lipid Peroxidation Assays: Ferroptosis, Resistance, and Tran

  2026-05-27

  This article provides a thought-leadership perspective for translational researchers on leveraging advanced lipid peroxidation assays to investigate ferroptosis and therapeutic resistance, particularly in the context of clear cell renal cell carcinoma (ccRCC). Blending mechanistic insight with strategic guidance, we decode the evolving role of malondialdehyde (MDA) quantification, highlight competitive assay innovations, and project the future of oxidative stress biomarker research.

• Molnupiravir Blocks Bourbon Virus in Mice: Preclinical Insig

  2026-05-26

  This study provides the first evidence that molnupiravir, a broad-spectrum antiviral, suppresses Bourbon virus (BRBV) infection and associated pathology in a mouse model. The findings highlight its potential as a therapeutic candidate for emerging tick-borne RNA viruses lacking approved treatments.

• A-1210477: Precision MCL-1 Inhibitor for Cancer Apoptosis As

  2026-05-26

  A-1210477 offers superior selectivity and nanomolar potency for dissecting MCL-1-dependent apoptosis in cancer research. This guide breaks down optimized workflows, comparative advantages, and troubleshooting strategies—empowering reliable, reproducible results in mitochondrial apoptosis assays.

• Nirmatrelvir (PF-07321332): Optimizing SARS-CoV-2 Assays in

  2026-05-25

  This expert guide addresses real-world experimental challenges in coronavirus research, showing how Nirmatrelvir (PF-07321332) (SKU B8579) enables reproducible, data-driven workflows for studying SARS-CoV-2 replication inhibition. Scenario-based Q&As highlight practical protocol optimization, data interpretation, and product selection, rooted in peer-reviewed evidence and APExBIO's validated quality.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-25

  Chen et al. provide a comprehensive analysis of carbapenemase-encoding gene (CEG) prevalence, transmission, and resistance in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals during 2022–2024. Their findings reveal high rates of plasmid-borne blaNDM-1, notable multidrug resistance, and efficient horizontal gene transfer, underscoring urgent challenges for infection control and antimicrobial stewardship.

413 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page